AQUINOX PHARMACEUTICALS, INC Separation Agreements
3 Contracts & Agreements
- Separation Agreement dated March 6, 2023 and effective March 31, 2023, by and between Neoleukin Therapeutics, Inc. and Jonathan Drachman (Filed With SEC on May 8, 2023)
- Separation Agreement dated March 31, 2023, by and between Neoleukin Therapeutics, Inc. and Priti Patel (Filed With SEC on May 8, 2023)
- Separation Agreement and Release, dated August 5, 2019, by and between Aquinox Pharmaceuticals, Inc., and David J. Main (Filed With SEC on August 6, 2019)
